[ Price : $8.95]
FDA warns Novo Nordisk in Plainsboro, NJ, about its failure to meet postmarketing adverse drug experience reporting requirements.[ Price : $8.95]
FDA warns Frances Fareva about CGMP violations in the production of finished drugs at its Morton Grove, IL, manufacturing facility...[ Price : $8.95]
FDA issues an early alert regarding a potential safety issue with certain Erbe USA Flexible Cryoprobes, following reports that som...[ Price : $8.95]
The Institute for Safe Medicines calls on FDA, the Federal Trade Commission, and the Department of Justice to take enforcement act...[ Price : $8.95]
Five Sidley attorneys recommend ways in which drug companies can analyze their direct-to-consumer promotions to see if they are li...[ Price : $8.95]
FDA cites a U.K.-based clinical research center for failing to promptly report adverse events and for potential falsification of s...[ Price : $8.95]
Vertex Pharmaceuticals says an interim analysis of its Phase 3 RAINIER trial showed its experimental therapy povetacicept signific...[ Price : $8.95]
FDA accepts for review a Capricor Therapeutics BLA resubmission for its experimental cell therapy deramiocel, intended to treat he...